Parametric Portfolio Associates’s Viemed Healthcare VMD Stock Holding History

Parametric Portfolio Associates’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$573K	Sell	115,086 -69,699	-38%	-$324K	﹤0.01%	3034
2021 Q4	$965K	Buy	184,785 +115,236	+166%	+$643K	﹤0.01%	2799
2021 Q3	$386K	Buy	69,549 +15,370	+28%	+$100K	﹤0.01%	3206
2021 Q2	$387K	Buy	54,179 +6,437	+13%	+$55.8K	﹤0.01%	3184
2021 Q1	$483K	Buy	47,742 +1,341	+3%	+$12.6K	﹤0.01%	3514
2020 Q4	$360K	Buy	46,401 +1,615	+4%	+$14.2K	﹤0.01%	3526
2020 Q3	$387K	Buy	+44,786	New	+$452K	﹤0.01%	3376

Other funds holding VMD

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Parametric Portfolio Associates's VMD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Viemed Healthcare (VMD) stake by 38% in Q1 2022, selling an estimated $324K and leaving 115,086 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #3034.

Parametric Portfolio Associates first reported a position in VMD in Q3 2020 and has held it in 7 quarters since. The position peaked at $965K in Q4 2021. 89 funds tracked by Wall St. Rank hold VMD as of Q1 2022.

Parametric Portfolio Associates held 115,086 shares of Viemed Healthcare worth $573K as of Q1 2022.
Parametric Portfolio Associates sold 69,699 Viemed Healthcare shares in Q1 2022, an estimated $324K.
Viemed Healthcare made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3034 holding.
Parametric Portfolio Associates first reported a position in Viemed Healthcare in Q3 2020 and has held it in 7 quarters since.
Parametric Portfolio Associates's Viemed Healthcare position peaked at $965K in Q4 2021.
89 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.